State of Tennessee, Department of Treasury
NBIX icon

State of Tennessee, Department of Treasury’s Neurocrine Biosciences NBIX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.79M Buy
40,272
+6,465
+19% +$959K 0.02% 499
2026
Q1 		$4.45M Hold
33,807
– – 0.02% 607
2025
Q4 		$4.6M Sell
33,807
-1,448
-4% -$210K 0.01% 607
2025
Q3 		$4.95M Sell
35,255
-7,943
-18% -$1.08M 0.02% 575
2025
Q2 		$5.43M Hold
43,198
– – 0.02% 527
2025
Q1 		$4.78M Hold
43,198
– – 0.02% 545
2024
Q4 		$5.9M Sell
43,198
-1,219
-3% -$151K 0.02% 502
2024
Q3 		$5.12M Buy
44,417
+3,088
+7% +$423K 0.02% 550
2024
Q2 		$5.69M Sell
41,329
-663
-2% -$90.9K 0.02% 496
2024
Q1 		$5.79M Sell
41,992
-5,000
-11% -$683K 0.02% 532
2023
Q4 		$6.19M Sell
46,992
-5,200
-10% -$599K 0.02% 466
2023
Q3 		$5.87M Buy
52,192
+8,749
+20% +$921K 0.02% 479
2023
Q2 		$4.1M Hold
43,443
– – 0.02% 536
2023
Q1 		$4.4M Sell
43,443
-2,836
-6% -$295K 0.02% 521
2022
Q4 		$5.53M Buy
46,279
+10,000
+28% +$1.17M 0.03% 449
2022
Q3 		$3.85M Buy
36,279
+2,619
+8% +$266K 0.02% 564
2022
Q2 		$3.28M Sell
33,660
-30,000
-47% -$2.77M 0.02% 609
2022
Q1 		$5.97M Hold
63,660
– – 0.02% 457
2021
Q4 		$5.42M Hold
63,660
– – 0.02% 529
2021
Q3 		$6.11M Sell
63,660
-6,340
-9% -$599K 0.02% 451
2021
Q2 		$6.81M Buy
+70,000
New +$6.71M 0.03% 444

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Tennessee, Department of Treasury's NBIX Position: Q2 2026 in Review

State of Tennessee, Department of Treasury increased its Neurocrine Biosciences (NBIX) stake by 19% in Q2 2026, buying an estimated $959K and bringing the position to 40,272 shares worth $6.79M. The position accounts for 0.02% of the portfolio, ranked #499.

State of Tennessee, Department of Treasury first reported a position in NBIX in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.81M in Q2 2021. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • State of Tennessee, Department of Treasury held 40,272 shares of Neurocrine Biosciences worth $6.79M as of Q2 2026.
  • State of Tennessee, Department of Treasury bought 6,465 Neurocrine Biosciences shares in Q2 2026, an estimated $959K.
  • Neurocrine Biosciences made up 0.02% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #499 holding.
  • State of Tennessee, Department of Treasury first reported a position in Neurocrine Biosciences in Q2 2021 and has held it in 21 quarters since.
  • State of Tennessee, Department of Treasury's Neurocrine Biosciences position peaked at $6.81M in Q2 2021.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.